MedTrace Logo

Menstrual Phase and Smoking Cessation at a State Quitline

NCT03908320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2020-10-19

No results posted yet for this study

Summary

Quitlines are efficient and cost-effective treatments for smoking cessation, yet little research has explored how to personalize and optimize quitline services for women. The goal of this project is to explore the feasibility and preliminary efficacy of a quitline intervention that considers the menstrual cycle as compared to standard care for cessation. If funded, the results of this study will directly inform future research on quitline smoking cessation interventions for premenopausal women, including a full scale clinical trial.

Conditions

  • Menstrual Cycle

Interventions

OTHER

Menstrual Cycle Timing

Quit date is set to menstrual phase.

OTHER

Menstrual Cycle Timing

Menstrual cycle timing of quit date is monitored

DRUG

NRT Patch

NRT patch is provided

BEHAVIORAL

Cessation Counseling

Cessation counseling is provided

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-05-31
Completion
2020-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03908320 on ClinicalTrials.gov